4th Annual MarketsandMarkets Orphan Drugs and Rare Diseases Conference

Topics

• Next Generation therapies treating uncommon/rare infections
• Current landscape of Orphan Drugs across the globe
• Clinical development & regulatory
• Practices to enhance access to patient data
• Existing roadblocks in orphan drug development
• Digital health and Artificial intelligence
• Revolutionary changes approaching rare diseases
• Pricing and marketing plans for orphan medications

Who should Attend

Attendees with responsibilities in:

• Molecular Geneticist
• Cell and Gene Therapy
• Personalized & Innovative Medicine
• Translational Science
• Regenerative Medicine
• External R&D Innovation
• Public, Regulatory, and Medical Affairs
• Rare and Ultra-Rare Diseases
• Market Access
• Patient Engagement
• Program Management
• Patient Advocacy Groups
• Health Economics Outcomes Research
• Clinical Research Organizations
• Speciality Pharmacies
• Investments and Funding